I have heard of cancer agents being used to help with sign and symptoms of CIPD. Exactly which agents are used and at what dose/frequency. What is their proposed mechanism of action?
Also how is methotrexate used - dose, frequency, mechanism of action? thanks, chris
The standard treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are intravenous immune globulin, steroids, and plasma exchange. If patients fail these therapies then immune modulating agents such as azathioprine, cyclosporine and cyclophosphamide have been used. The doses and frequency vary from patient to patient depending upon weight, other medical conditions, other medications, and renal and liver function. I would encourage you to obtain an appointment with your neurologist to discuss these options. Good luck.
Copyright 1994-2017MedHelp International.All rights reserved. MedHelp is a division of Aptus Health.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.